Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
3 of 6 columns
Comparison
| Attribute | Ratio Therapeutics, Inc.5.8remove | LifeCyte Innovations, Inc.5.8remove | PLEOPHARMA, INC.5.5remove |
|---|---|---|---|
| Signal scores | |||
| Radar composite | 5.8 | 5.8 | 5.5 |
| IPO signal score | 11.6 | 11.6 | 11.0 |
| Tokenization signal score | 0.0 | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 | 0.0 |
| Momentum | STABLE0.0 | STABLE+3.0 | STABLE+0.2 |
| Company | |||
| Stage | private | private | private |
| Sector | Health Care | Health Care | Health Care |
| Headquarters | BOSTON, United States | GREENSBORO, United States | PHOENIXVILLE, United States |
| Founded | not on record | 2024 | not on record |
| Employees | not on record | not on record | not on record |
| Capital | |||
| Latest valuation | not on record | not on record | not on record |
| Total funding | $70M | $1M | $6M |
| Latest round | Private Placement $70M | Private Placement $1M | Private Placement $6M |
| Investors on record | 0 | 0 | 0 |
| Evidence | |||
| Institutional relationships | 0 | 0 | 0 |
| Active signals | 1 | 1 | 2 |
| Confidence | 53% | 53% | 55% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.